
Please try another search
By Sam Boughedda
Investing.com — Shares of French vaccine company Valneva SE ADR (NASDAQ:VALN) surged 24% Wednesday on news that the European Commission has approved an agreement that will see the company supply up to 60 million doses of its Covid-19 vaccine over two years.
The deal includes approximately 27 million doses in 2022, with the EC having an option to increase its initial purchase to a total of 60 million doses by the end of 2023.
Valneva's Nasdaq-listed shares traded around $50.33 mark following the news.
According to an article from Dr. Amir Khan at Al Jazeera, Valneva's vaccine is different from other Covid-19 vaccines in that it aims to stimulate an immune response to the entire virus, rather than just the spike protein.
"We are deeply committed to bringing an alternative vaccine solution to the market as quickly as possible and continue to work tirelessly to achieve that," said Thomas Lingelbach, Valneva's CEO.
"Our Phase 3 results confirmed the advantages often associated with inactivated vaccines and we continue to believe that our differentiated vaccine candidate could make an important contribution to the global fight against the COVID-19 pandemic," he added.
(Reuters) - Rivian Automotive said on Friday Charly Mwangi, who helped kick-start the electric-vehicle maker's manufacturing process, will leave the company. Mwangi, a former...
LONDON (Reuters) - Low-cost carrier easyJet (LON:EZJ) is to cancel more than 200 flights over the next 10 days due to airport delays and other restrictions, disrupting travel...
SHANGHAI (Reuters) - China's first public real estate investment trusts (REITs) based on residential properties will be launched soon, as regulators step up efforts to channel...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.